TECNOLOGÍA PARA LA MONITORIZACIÓN Y CONTROL DE LA DIABETES

VolverVolver

Resultados 87 resultados LastUpdate Última actualización 16/01/2021 [16:37:00] pdf PDF xls XLS

Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days



Página1 de 4 nextPage   por página


BLOOD GLUCOSE MONITORING METHOD AND WEARABLE BLOOD GLUCOSE MONITORING DEVICE USING SAME

NºPublicación: EP3763291A1 13/01/2021

Solicitante:

BIOMEDILABS CO LTD [KR]

KR_20190105422_A

Resumen de: EP3763291A1

Disclosed are a blood glucose monitoring method and a PPG-based blood glucose monitoring device for same in which a reference sample is prepared by means of preparing a human body substitute dummy and reference blood from which blood glucose is removed and applying quasi-blood to the dummy, the signal amount of each wavelength band with respect to the reference sample to which the reference blood is applied is measured by means of a blood glucose monitoring device, reference signal amount data is obtained and provided as basic data, irradiation light of a plurality of light sources is radiated on a body part of a subject for blood glucose monitoring by means of the blood glucose monitoring device of the present invention, a light-receiving element receives reflected light and scattered light and thus the signal amount of each wavelength band is obtained, a differential signal amount for each wavelength band, which is a corresponding reference signal amount for each wavelength band comprised in the basic data subtracted from the signal amount for each wavelength band with respect to the body part of the subject for blood glucose monitoring, is obtained, and a blood glucose amount corresponding to the differential signal amount for each wavelength band is calculated by means of the correlation between the differential signal amount for each wavelength band and the blood glucose amount.

traducir

METHODS OF INCORPORATING CGM DATA INTO DIABETES THERAPY

NºPublicación: US2021001044A1 07/01/2021

Solicitante:

TANDEM DIABETES CARE INC [US]

Resumen de: US2021001044A1

Disclosed herein are apparatuses and methods incorporating an infusion pump and a CGM that can include software that automatically populates a blood glucose section of a bolus calculator with a most recent valid CGM value. The software can additionally be programmed to automatically populate the bolus calculator with a single CGM reading only when one or more predefined conditions are met that aid in mitigating the risk of inaccurate and/or invalid single CGM readings.

traducir

USER-WORN DEVICE FOR NONINVASIVELY MEASURING A PHYSIOLOGICAL PARAMETER OF A USER

NºPublicación: US2021000392A1 07/01/2021

Solicitante:

MASIMO CORP [US]

US_2020229738_A1

Resumen de: US2021000392A1

The present disclosure relates to noninvasive methods, devices, and systems for measuring various blood constituents or analytes, such as glucose. In an embodiment, a light source comprises LEDs and super-luminescent LEDs. The light source emits light at at least wavelengths of about 1610 nm, about 1640 nm, and about 1665 nm. In an embodiment, the detector comprises a plurality of photodetectors arranged in a special geometry comprising one of a substantially linear substantially equal spaced geometry, a substantially linear substantially non-equal spaced geometry, and a substantially grid geometry.

traducir

Near-IR glucose sensors

NºPublicación: AU2019293250A1 07/01/2021

Solicitante:

PROFUSA INC

US_2020000383_A1

Resumen de: AU2019293250A1

Glucose-sensing luminescent dyes, polymers, and sensors are provided. Additionally, systems including the sensors and methods of using these sensors and systems are provided.

traducir

CONTACTLESS DEVICE FOR MEASURING BLOOD SUGAR

NºPublicación: EP3761441A1 06/01/2021

Solicitante:

MARGGRAF [FR]
UNIV DE LORRAINE [FR]

Resumen de: EP3761441A1

Un dispositif de mesure de la glycémie dans un corps vivant comporte une antenne (1) destinée à être placée à proximité du corps vivant, une unité électronique (2) pour alimenter l'antenne (1) et mesurer un signal de retour de l'antenne (1). L'antenne (1, 1') comporte :- une ligne de transmission (10, 10') s'étendant sur une première face (11) ou une deuxième face (12) d'un substrat diélectrique plan et connectée à l'unité électronique (2) ;- un plan de masse (13) s'étendant sur au moins une partie de la deuxième face (12) du substrat ;- au moins un résonateur (14) s'étendant sur la première face (11) à proximité de la ligne de transmission (10, 10') ;l'unité électronique (2) étant prévue pour fournir à l'antenne (1) un signal à une fréquence prédéterminée comprise entre 0,9 et 1,6 GHz, mesurer un signal de retour, déterminer les caractéristiques électriques de l'antenne (1) et en déduire un taux de glycémie dans le corps vivant.

traducir

APPARATUS, SYSTEM AND METHOD FOR CHRONIC DISEASE MONITORING

NºPublicación: US2020405157A1 31/12/2020

Solicitante:

RESMED SENSOR TECH LTD [IE]

US_2017231504_A1

Resumen de: US2020405157A1

An apparatus, system, and method for monitoring a person suffering from a chronic medical condition predicts and assesses physiological changes which could affect the care of that subject. Examples of such chronic diseases include (but are not limited to) heart failure, chronic obstructive pulmonary disease, asthma, and diabetes. Monitoring includes measurements of respiratory movements, which can then be analyzed for evidence of changes in respiratory rate, or for events such as hypopneas, apneas and periodic breathing. Monitoring may be augmented by the measurement of nocturnal heart rate in conjunction with respiratory monitoring. Additional physiological measurements can also be taken such as subjective symptom data, blood pressure, blood oxygen levels, and various molecular markers. Embodiments for detection of respiratory patterns and heart rate are disclosed, together with exemplar implementations of decision processes based on these measurements.

traducir

TRANSCUTANEOUS ANALYTE SENSOR

NºPublicación: US2020405203A1 31/12/2020

Solicitante:

DEXCOM INC [US]

US_2020367794_A1

Resumen de: US2020405203A1

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host.

traducir

Methods and Systems for the Detection of Disease

NºPublicación: US2020405214A1 31/12/2020

Solicitante:

JMLK35 LLC [US]

US_2016192873_A1

Resumen de: US2020405214A1

Disclosed herein are systems and methods for the detection of alterations in glucose metabolism in a subject. The disclosed methods and systems provide, in certain embodiments, administering a first eye test to the subject when the subject is in a normal state, obtaining a first set of one or more images of the first eye test of the subject, administering a second eye test to the subject and obtaining a second set of one or more images of the second eye test of the subject. The methods further provide for analyzing one or more differences identified between the first set of one or more images and the second set of one or more images.

traducir

CLOSED-LOOP GLUCOSE AND/OR INSULIN CONTROL SYSTEM

NºPublicación: US2020405224A1 31/12/2020

Solicitante:

MEDTRONIC MINIMED INC [US]

US_2017325736_A1

Resumen de: US2020405224A1

Disclosed are a method and/or system for determining a suggested change in a recommended therapy for a patient based, at least in part, on sensor measurements, and generating an alert to an attendant in a hospital environment upon detection of the suggested change. In another embodiment, a method and/or system is directed to automatically determining a maximum interval to alert an attendant following receipt of a measurement at an operator interface. In yet another embodiment, a method and/or system is directed to blood-glucose sensor calibration.

traducir

ANALYTE SENSOR

NºPublicación: EP3756537A1 30/12/2020

Solicitante:

DEXCOM INC [US]

EP_3649925_A1

Resumen de: EP3756537A1

Herein is disclosed a glucose measuring system, the system comprising an on-skin device configured to measure, process and store glucose sensor data, the on-skin device including a mounting unit adapted for mounting on a skin of a host, an electronics unit connected to the mounting unit, the electronics unit configured to perform the processing and storing, and a sensor for measuring a level of glucose in a host, the sensor comprising an in vivo portion for insertion through the skin at an exit site of the host and an ex vivo portion connected to the mounting unit, wherein the sensor is operably connected to the electronics unit; and a receiver for receiving and processing the glucose sensor data, and displaying the processed glucose sensor data on a user interface of the receiver, wherein the on-skin device is configured to transmit stored glucose sensor data when requested by the receiver, wherein the receiver requests the on-skin device to transmit the requested stored glucose sensor data when the receiver is held in close proximity to the device, and wherein the requesting and transmission use inductive coupling data transmission.

traducir

SYSTEMS AND METHODS FOR MULTIPLE ANALYTE ANALYSIS

NºPublicación: EP3757574A1 30/12/2020

Solicitante:

ROCHE DIABETES CARE GMBH [DE]
HOFFMANN LA ROCHE [CH]

KR_20190084358_A

Resumen de: EP3757574A1

Systems and methods for multiple analyte analysis are provided. In one embodiment, a method includes determining concentrations of first and second analytes in a sample. The first and second analytes may be, for example, glucose and hydroxybutyrate. In this form, an indication related to the measured concentration of hydroxybutyrate is provided in response to determining that the concentration of hydroxybutyrate is above a predetermined value. In a further aspect of this form, a quantitative indication representative of the measured glucose concentration is automatically provided regardless of the value of the measured glucose concentration. In another embodiment, a system includes a meter configured to interact with a test element to assess first and second analytes in a sample. Further embodiments, forms, objects, features, advantages, aspects, and benefits shall become apparent from the description and drawings.

traducir

ELECTRONIC DEVICE, ESTIMATION SYSTEM, ESTIMATION METHOD, AND ESTIMATION PROGRAM

NºPublicación: EP3756539A1 30/12/2020

Solicitante:

KYOCERA CORP [JP]

KR_20200106923_A

Resumen de: EP3756539A1

Provided is an electronic device 100 including a sensor unit 130 configured to acquire a pulse wave of a subject and a controller 143 configured to estimate, using an estimation formula created based on a preprandial blood glucose level and a postprandial pulse wave and blood glucose level, an amount of change in the blood glucose level of the subject due to meal based on a postprandial pulse wave of the subject acquired by the sensor unit 130 and to estimate a postprandial blood glucose level of the subject based on the estimated amount of change and the preprandial blood glucose level of the subject.

traducir

ELECTRONIC DEVICE, ESTIMATION SYSTEM, ESTIMATION METHOD, AND ESTIMATION PROGRAM

NºPublicación: EP3756540A1 30/12/2020

Solicitante:

KYOCERA CORP [JP]

CN_111683590_A

Resumen de: EP3756540A1

Provided is an electronic device 100 including a sensor unit 130 configured to acquire a pulse wave of a subject and a controller 143 configured to estimate, using an estimation formula created based on a preprandial pulse wave and a postprandial pulse wave and blood glucose level, a postprandial blood glucose level of the subject based on a difference between the preprandial pulse wave and the postprandial pulse wave of the subject acquired by the sensor unit 130.

traducir

DEVICE FOR NON-INVASIVE MEASUREMENT OF BLOOD SUGAR LEVEL

NºPublicación: PL3359038T3 28/12/2020

Solicitante:

DIA VIT LTD [GB]

US_2018317821_A1

Resumen de: WO2017060746A1

The object of the invention is a device that allows measuring blood sugar levels in mammals— primarily humans— by measuring the refraction of electromagnetic radiation from the skin or body tissue, without the need for invasive sampling, such as penetrating or pricking the skin. The device uses the blue light portion of the visible spectrum and near- infrared (IR) radiation as a source of electromagnetic radiation. The device falls within the field of medical diagnostics and is essentially designed to be portable, so that the users can wear it on their wrists, for example. The signals of reflected light/radiation measured by the sensor unit are filtered by the frequency filtering set and mathematically processed in order to Calculate the current blood sugar level. The accuracy of the measurement result of the device is comparable to the results obtained with the standard method of measuring by blood sampling. A method for measuring of blood sugar level using said device is also disclosed.

traducir

DYNAMIC EQUIVALENT ON BOARD ESTIMATOR

NºPublicación: US2020402633A1 24/12/2020

Solicitante:

DEXCOM INC [US]

WO_2020257667_A1

Resumen de: US2020402633A1

Adaptive on board estimation of exogenous pharmacon responsive to transient (i.e., impermanent) physiological effects is provided. Dynamically estimating an equivalent amount of an exogenous pharmacon on board (XOB), such as insulin and/or carbohydrates, left in the subject, is based on predictions of glucose time-series data. These estimated values, such as insulin on board (IOB), are useful for diabetes management software, including decision support and/or artificial pancreas (AP) algorithms, for example.

traducir

DYNAMIC EQUIVALENT ON BOARD ESTIMATOR

NºPublicación: US2020402634A1 24/12/2020

Solicitante:

DEXCOM INC [US]

WO_2020257667_A1

Resumen de: US2020402634A1

Adaptive on board estimation of exogenous pharmacon responsive to transient (i.e., impermanent) physiological effects is provided. Dynamically estimating an equivalent amount of an exogenous pharmacon on board (XOB), such as insulin and/or carbohydrates, left in the subject, is based on predictions of glucose time-series data. These estimated values, such as insulin on board (JOB), are useful for diabetes management software, including decision support and/or artificial pancreas (AP) algorithms, for example.

traducir

DYNAMIC EQUIVALENT ON BOARD ESTIMATOR

NºPublicación: WO2020257667A1 24/12/2020

Solicitante:

DEXCOM INC [US]

US_2020402634_A1

Resumen de: WO2020257667A1

Adaptive on board estimation of exogenous pharmacon responsive to transient (i.e., impermanent) physiological effects is provided. Dynamically estimating an equivalent amount of an exogenous pharmacon on board (XOB), such as insulin and/or carbohydrates, left in the subject, is based on predictions of glucose time-series data. These estimated values, such as insulin on board (IOB), are useful for diabetes management software, including decision support and/or artificial pancreas (AP) algorithms, for example.

traducir

SYSTEM AND METHOD FOR WEARABLE MEDICAL SENSOR AND NEURAL NETWORK BASED DIABETES ANALYSIS

NºPublicación: WO2020257158A1 24/12/2020

Solicitante:

UNIV PRINCETON [US]

Resumen de: WO2020257158A1

According to various embodiments, a machine-learning based system for diabetes analysis is disclosed. The system includes one or more processors configured to interact with a plurality of wearable medical sensors (WMSs). The processors are configured to receive physiological data from the WMSs and demographic data from a user interface. The processors are further configured to train at least one neural network based on a grow-and-prune paradigm to generate at least one diabetes inference model. The neural network grows at least one of connections and neurons based on gradient information and prunes away at least one of connections and neurons based on magnitude information. The processors are also configured to output a diabetes-based decision by inputting the received physiological data and demographic data into the generated diabetes inference model.

traducir

SYSTEM AND METHOD FOR INSULIN PUMP MEDICAL DEVICE INCLUDING A SLIDER ASSEMBLY WHEREIN IMAGES ON DISPLAY ALLOW FOR HIGHLIGHTING AND MAGNIFYING IMAGES

NºPublicación: US2020397982A1 24/12/2020

Solicitante:

DEKA PRODUCTS LP [US]

US_2020069869_A1

Resumen de: US2020397982A1

A medical system includes an input assembly for receiving one or more user inputs. The input assembly includes at least one slider assembly for providing an input signal. Processing logic receives the input signal from the input assembly and provides a first output signal and a second output signal. A display assembly is configured to receive, at least in part, the first output signal from the processing logic and render information viewable by the user. The second output signal is provided to one or more medical system components. The information rendered on the display assembly may be manipulatable by the user and at least a portion of the information rendered may be magnified.

traducir

DYNAMIC EQUIVALENT ON BOARD ESTIMATOR

NºPublicación: US2020402635A1 24/12/2020

Solicitante:

DEXCOM INC [US]

WO_2020257667_A1

Resumen de: US2020402635A1

Adaptive on board estimation of exogenous pharmacon responsive to transient (i.e., impermanent) physiological effects is provided. Dynamically estimating an equivalent amount of an exogenous pharmacon on board (XOB), such as insulin and/or carbohydrates, left in the subject, is based on predictions of glucose time-series data. These estimated values, such as insulin on board (JOB), are useful for diabetes management software, including decision support and/or artificial pancreas (AP) algorithms, for example.

traducir

CHEMICAL ABLATION AND METHOD OF TREATMENT FOR VARIOUS DISEASES

NºPublicación: US2020398032A1 24/12/2020

Solicitante:

NEUROTRONIC INC [US]

Resumen de: US2020398032A1

Embodiments of the present invention provide a device and a method for treating at least one of hypertension, pulmonary arteries, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pain, asthma or chronic obstructive pulmonary disease by delivering an effective amount of a formulation to a tissue. In embodiments of the present invention, the formulation may include at least one of a gas, a vapor, a liquid, a solution, an emulsion, or a suspension of one or more ingredients. In embodiments of the present invention, amounts of the formulation and/or energy are effective to injure or damage tissue, nerves, and nerve endings in order to relieve disease symptoms.

traducir

A TECHNIQUE TO ANALYSE GLUCOSE LEVELS USING BIO SWEAT SENSOR

NºPublicación: AU2020103057A4 24/12/2020

Solicitante:

PARTHASARATHY V
ARUNACHALAM M
ANUSHA K
KARUPPATHAL R
KRISHNAN RAJKUMAR
ILANKUMARAN S
SUDHA R
ANCHITAALAGAMMAI J
N SASIKALA

Resumen de: AU2020103057A4

A TECHNIQUE TO ANALYSE GLUCOSE LEVELS USING BIO-SWEAT SENSOR The blood glucose is the main indicator for the patient's health, particularly for the symptoms of diabetes mellitus. In recent days, the diabetic patients have increased enormously, and this had led to approach the study of glucose measurement in order to enable the correct monitoring of glucose level. The electrochemical analysis is the simple method, and its technology has incorporated to the research level from strips to wearable devices and the implantable method. The non-invasive method will estimate the blood glucose levels with the help of sweat. The wearable sensors had a major role in continuous and non-invasive monitoring of the diabetes. The occurrence of diabetes is due to food or gene and that can be predicted with the help of machine learning to take some important precautions. The blood glucose monitoring by using the sweat will help the individual from painful method like blood-based monitoring. The new method is painless, cost-effective, and monitoring is easy for measuring the glucose. 11 P a g e A TECHNIQUE TO ANALYSE GLUCOSE LEVELS USING BIO-SWEAT SENSOR Drawings: atab ase - Data Test Data process-Ing SPlitting! - Machine! __EClssifictior Learning Prediction Traning _Agirth Rule Machine Learnrng Model Result Predicto Sw eat C cV Glucose Real-Tinme Input PM Les~ltveR . Monitoring Unit PowCud Figure 1: Block Diagram of proposed Method 1 P a g e

traducir

SYSTEM AND METHOD FOR ADJUSTING INSULIN DELIVERY

NºPublicación: US2020397989A1 24/12/2020

Solicitante:

BIGFOOT BIOMEDICAL INC [US]

US_2018200436_PA

Resumen de: US2020397989A1

The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include receiving and/or determining one or more user specific dosage parameters.

traducir

Subcutaneous Outpatient Management

NºPublicación: US2020402636A1 24/12/2020

Solicitante:

ASEKO INC [US]

US_2019348166_A1

Resumen de: US2020402636A1

A method includes receiving glucose data of a patient at a glucometer having a display. The glucose data includes a glucose measurement measured by the glucometer and a glucose time associated with the glucose measurement. The method also includes obtaining patient information associated with the patient that includes a target blood glucose for the patient and a correction factor. The method also includes when the glucose measurement of the patient exceeds the target blood glucose for the patient, calculating a correction dose of insulin based on a function of the glucose measurement of the patient, the target blood glucose for the patient, and the correction factor. The method also includes displaying the correction dose of insulin on the display of the glucometer.

traducir

Apparatus and Method for Taking Blood Glucose Measurements and Recommending Insulin Doses

Nº publicación: US2020402655A1 24/12/2020

Solicitante:

HYGIEIA INC [US]

US_2018226152_A1

Resumen de: US2020402655A1

The present disclosure related to an apparatus that may be used for taking blood glucose measurements and providing individualized insulin dose recommendations wherein the apparatus is easy to use and facilitates improved diabetes control in patients. Also disclosed are related methods.

traducir

Página1 de 4 nextPage por página

punteroimgVolver